高脂血症・動脈硬化とメタボリックシンドローム

機関リポジトリ Web Site 被引用文献1件

書誌事項

タイトル別名
  • コウシケツショウ ドウミャク コウカ ト メタボリック シンドローム
  • Clinical significance of lipid disorders and atherosclerosis in metabolic syndrome
  • コウシケッショウ ドウミャク コウカ ト メタボリック シンドローム

この論文をさがす

抄録

The cardiovascular disease has been increasingly recognized over the last decade. The metabolic syndrome is associated with increased risk for development of dyslipidemia leading to atherosclerosis. In addition to healthy lifestyle promotion, treatment of atherogenic dyslipidemia using lipid lowering agents such as fibrates and statins is useful. In fact, bezafibrate reduces the incidence of myocardial infarction in patients with metabolic syndrome during long-term follow-up. Early detection of atherosclerosis including endothelial dysfunction is very important strategy for preventing cardiovascular events in patients with metabolic syndrome. We attempt to establish multiphasic health testing system（Anti-Aging Medical Center : AAMC）using recently-developed devices for medical diagnosis in Tokushima University Hospital.

収録刊行物

被引用文献 (1)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ